IL13RA1 and breast carcinoma: Taken together, our findings suggest that stage-dependent ILC2 activation might induce differential functioning of MDSCs through IL-13/IL-13Rα1 signaling during cancer progression from micro- to macrometastasis in breast cancer lung metastasis.